Deerfield, Ill. - May 15, 2018
Baxter International Inc. (NYSE: BAX) will host an investor conference on Monday, May 21, 2018 in New York City at the Pierre Hotel. The investor conference will feature an innovation hall displaying product and therapy advancements from Baxter’s pipeline beginning at 7:00 a.m. EDT, and will again be available following the conclusion of the formal presentations at 12:30 p.m. EDT. Presentations by members of the Baxter management team will commence at 8:00 a.m. EDT.
The meeting and accompanying slides will be webcast live by Q4 Inc. and will be accessible from Baxter’s corporate website at: www.baxter.com. The meeting will be recorded by Baxter as copyrighted material and cannot be recorded or rebroadcast without Baxter’s permission. To register for the conference, please click on the following link: Event Details & Registration.
Baxter provides a broad portfolio of essential healthcare products across its portfolio, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.